SCHEMBL13877912

SCHEMBL13877912

Cc1c[nH]c(C(=O)Nc2ccc([C@@]3(O)C[C@@]4(C)O[C@@](C)(C3)[C@H](O)[C@@H]4O)cc2C2=CCC(C)(C)CC2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19264778 0.96 — —
SCHEMBL13877911 0.92 — —
SCHEMBL14374730 0.90 — —
SCHEMBL13877909 0.90 — —
SCHEMBL13877987 0.89 — —
SCHEMBL4236246 0.89 — —
SCHEMBL14383682 0.88 — —
SCHEMBL14374725 0.87 — —
SCHEMBL13877930 0.86 — —
SCHEMBL13877928 0.85 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8497376-B2 4-Cyano-1H-imidazole-2-carboxylic acid [2-cyclohex-1-enyl-4-(2,6-dioxo-piperidin-4-yl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent JANSSEN PHARMACEUTICA N.V. (BE) 2013-07-30 — — US disclosed
US-20090105296-A1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-23 — — US disclosed
Send feedback